Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

One-Third of Surveyed Device Firms Expect Increased Customer Base From ACA

This article was originally published in The Gray Sheet

Executive Summary

The survey of 123 device executives sponsored by MassMEDIC probed the impact of the Affordable Care Act. Of the 33 percent who expect an increase in patient customer base from the insurance expansion, about one-quarter said it would be enough to counter the negative impact of the device excise tax.

You may also be interested in...



ACA Countdown: Details Emerging On Exchanges, Medicaid Expansion

Open enrollment in state exchange plans kicks off Oct. 1 and expanded Medicaid eligibility Jan. 1, and many states offer a preliminary view of how coverage will play out under the Affordable Care Act in 2014.

Device Industry Amps Up Efforts To Repeal Device Tax In Lame Duck Session

Industry groups flew in more than 50 CEOs to visit Capitol Hill, launched an ad campaign and released an impact report last week as part of a stepped-up effort to get Congress to repeal the impending medical device tax before it goes into effect Jan. 1.

Second EU MDR Notified Body Designated In France

Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032027

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel